Healthcare -
Biotechnology - NASDAQ - US
$ 31.49
-0.317 %
$ 14 B
Market Cap
12.4
P/E
RPRX - TOTAL CURRENT LIABILITIES
Total Current Liabilities RPRX - Royalty Pharma plc
161 M
LAST VALUE
-2.93%
2 YEAR CAGR
-22.58%
5 YEAR CAGR
0.00%
10 YEAR CAGR